Qube Research & Technologies (QRT)’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Qube Research & Technologies (QRT)'s PCVX Position: Q3 2026 in Review
Qube Research & Technologies (QRT) sold out of Vaxcyte (PCVX) in Q3 2026, closing a stake of 363,205 shares — an estimated $21.1M sold.
Qube Research & Technologies (QRT) first reported a position in PCVX in Q2 2022 and held it in 7 quarters. The position peaked at $26.3M in Q2 2025. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Qube Research & Technologies (QRT) reported no remaining Vaxcyte position as of Q3 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 363,205 Vaxcyte shares in Q3 2026, an estimated $21.1M.
- Qube Research & Technologies (QRT) first reported a position in Vaxcyte in Q2 2022 and held it in 7 quarters.
- Qube Research & Technologies (QRT)'s Vaxcyte position peaked at $26.3M in Q2 2025.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.